As global pharmaceutical firms continue to see healthcare demand, price control policies and drug development costs rise, they need the right locations and the most effective networks more than ever before.
A trio of federal program announcements during Q1 2024 unleash funds, people and resources intended to enhance the economic development, health and vitality of under-resourced and overstressed communities and sites.